Cargando…
Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
Since the outbreak of the novel coronavirus nearly 3 years ago, the world’s public health has been under constant threat. At the same time, people’s travel and social interaction have also been greatly affected. The study focused on the potential host targets of SARS-CoV-2, CD13, and PIKfyve, which...
Autores principales: | Ruan, Zijing, Tang, Jiaxi, Zeng, Mingtang, Fan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329278/ https://www.ncbi.nlm.nih.gov/pubmed/37426619 http://dx.doi.org/10.1515/biol-2022-0637 |
Ejemplares similares
-
PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022) -
Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening
por: Sanchez, Mateo I., et al.
Publicado: (2019) -
Aminopeptidase N inhibitors and SARS
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2003) -
Computational study of novel natural inhibitors targeting aminopeptidase N(CD13)
por: Ge, Junliang, et al.
Publicado: (2020) -
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
por: Kang, Yuan-Lin, et al.
Publicado: (2020)